US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines

This publication has 40 references indexed in Scilit:

• CAR T-Cell Therapy in the Older Person: Indications and Risks
  Current Oncology Reports, 2022
• Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
  JAMA Oncology, 2021
• Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older
  Cancer, 2021
• Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
  Cancer, 2020
• Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
  Transplantation and Cellular Therapy, 2020
• Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
  Transplantation and Cellular Therapy, 2020
• Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study
  Transplantation and Cellular Therapy, 2015
• Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients
  Transplantation and Cellular Therapy, 2013
• Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
  JAMA, 2011
• Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
  Journal of Chronic Diseases, 1960